64 / 83
S
adalla
JC
et
al
.
542
R
ev
A
ssoc
M
ed
B
ras
2015; 61(6):536-542
28. Roque DR, WyshamWZ, Soper JT. The surgical management of cervical cancer:
an overview and literature review. Obstet Gynecol Surv. 2014; 69(7):426-41.
29.
Pareja R, Rendón GJ, Vasquez M, Echeverri L, Sanz-Lomana CM, Ramirez
PT. Immediate radical trachelectomy versus neoadjuvant chemotherapy
followed by conservative surgery for patients with stage IB1 cervical cancer
with tumors 2 cm or larger: A literature review and analysis of oncological
and obstetrical outcomes. Gynecol Oncol. 2015; 137(3):574-80. 30.
30.
Buekers TE, Anderson B, Sorosky JI, Buller RE. Ovarian function after
surgical treatment for cervical cancer. Gynecol Oncol. 2001; 80(1):85-8.
31.
Dursun P, Ayhan A, Yanik FB, Ku
ş
çu E. Ovarian transposition for the
preservation of ovarian function in young patients with cervical carcinoma.
Eur J Gynaecol Oncol. 2009; 30(1):13-5.
32.
Rasool N, Rose PG. Fertility-preserving surgical procedures for patients
with gynecologic malignancies. Clin Obstet Gynecol. 2010; 53(4):804-14.
33. Chhabra S, Kutchi I. Fertility preservation in gynecological cancers. Clin
Med Insights Reprod Health. 2013; 7:49-59.
34.
Lécuru F, Mathevet P, Querleu D, Leblanc E, Morice P, Daraï E et al. Bilateral
negative sentinel nodes accurately predict absence of lymph node metastasis
in early cervical cancer: results of the SENTICOL study. J Clin Oncol. 2011;
29(13):1686-91.
35.
Bats AS, Mathevet P, Buenerd A, Orliaguet I, Mery E, Zerdoud S et al. The
sentinel node technique detects unexpected drainage pathways and allows
nodal ultrastaging in early cervical cancer: insights from the multicenter
prospective SENTICOL study. Ann Surg Oncol. 2013; 20(2):413-22.
36.
Kadkhodayan S, Hasanzadeh M, Treglia G, Azad A, Yousefi Z, Zarifmahmoudi
L et al. Sentinel node biopsy for lymph nodal staging of uterine cervix cancer:
a systematic review and meta-analysis of the pertinent literature. Eur J Surg
Oncol. 2015; 41(1):1-20.
37. Tax C, Rovers MM, de Graaf C, Zusterzeel PL, Bekkers RL. The sentinel node
procedure in early stage cervical cancer, taking the next step; a diagnostic
review. Gynecol Oncol. 2015;pii:S0090-8258(15)30137-2.
38.
Banerjee R, Kamrava M. Brachytherapy in the treatment of cervical cancer:
a review. Int J Womens Health. 2014; 6:555-64.
39. Tanderup K, Viswanathan AN, Kirisits C, Frank SJ. Magnetic resonance
image guided brachytherapy. Semin Radiat Oncol. 2014; 24(3):181-91.
40. Vargo JA, Beriwal S. Image-based brachytherapy for cervical cancer. World
J Clin Oncol. 2014; 5(5):921-30.
41.
Dutta S, Nguyen NP, Vock J, Kerr C, Godinez J, Bose S et al. Image-guided
radiotherapy and brachytherapy for cervical cancer. Front Oncol. 2015;
5:64.
42.
Harkenrider MM, Alite F, Silva SR, Small W Jr. Image-based brachytherapy
for the treatment of cervical cancer. Int J Radiat Oncol Biol Phys. 2015;
92(4):921-34.
43.
Leath CA, Straughn JM Jr. Chemotherapy for advanced and recurrent cervical
carcinoma: results from cooperative group trials. Gynecol Oncol. 2013;
129(1):251-7.
44.
Pfaendler KS, Tewari KS. Changing paradigms in the systemic treatment of
advanced cervical cancer. Am J Obstet Gynecol. 2015; pii:S0002-9378(15)00772-3.
45. Tomao F, Papa A, Rossi L, Zaccarelli E, Caruso D, Zoratto F et al. Angiogenesis
and antiangiogenic agents in cervical cancer. Onco Targets Ther. 2014;
7:2237-48.
46.
Jackson MW, Rusthoven CG, Fisher CM, Schefter TE. Clinical potential of
bevacizumab in the treatment of metastatic and locally advanced cervical
cancer: current evidence. Onco Targets Ther. 2014; 7:751-9.
47.
Petit R, Basu P. ADXS11-001 immunotherapy targeting HPV-E7: preliminary
survival data from a phase II study in Indian women with recurrent/refractory
cervical cancer [abstract]. Presented at 2012 American Society of Clinical
Oncology Annual Meeting; June 1-5, 2012; Chicago, IL.
48. Delpech Y, Tulpin L, Bricou A, Barranger E. Lymph node surgical staging for
locally advanced cervical cancer. Gynecol Obstet Fertil. 2010; 38(1):30-5.
49.
Uzan C, Gouy S, Pautier P, Haie-Meder C, Duvillard P, Narducci F et al. Para-
aortic lymphadenectomy in advanced-stage cervical cancer: standard
procedure in 2010?. Gynecol Obstet Fertil. 2010; 38(11):668-71.
50.
Uzan C, Souadka A, Gouy S, Debaere T, Duclos J, Lumbroso J et al. Analysis
of morbidity and clinical implications of laparoscopic para-aortic
lymphadenectomy in a continuous series of 98 patients with advanced-stage
cervical cancer and negative PET-CT imaging in the para-aortic area.
Oncologist. 2011; 16(7):1021-7.
51.
Smits RM, Zusterzeel PL, Bekkers RL. Pretreatment retroperitoneal para-
aortic lymph node staging in advanced cervical cancer: a review. Int J Gynecol
Cancer. 2014; 24(6):973-83.
52. Chantalat E, Vidal F, Leguevaque P, Lepage B, Mathevet P, Deslandres M et
al. Cervical cancer with paraaortic involvement: do patients truly benefit
from tailored chemoradiation therapy? A retrospective study on 8 French
centers. Eur J Obstet Gynecol Reprod Biol. 2015; 193:118-22.
53.
Hwang L, Bailey A, Lea J, Albuquerque K. Para-aortic nodal metastases in
cervical cancer: a blind spot in the International Federation of Gynecology
and Obstetrics staging system: current diagnosis and management. Future
Oncol. 2015; 11(2):309-22.
54.
Sardain H, Lavoue V, Redpath M, Bertheuil N, Foucher F, Levêque J. Curative
pelvic exenteration for recurrent cervical carcinoma in the era of concurrent
chemotherapy and radiation therapy. A systematic review. Eur J Surg Oncol.
2015; 41(8):975-85.
55. Ang C, Bryant A, Barton DP, Pomel C, Naik R. Exenterative surgery for
recurrent gynaecological malignancies (Review). Cochrane Database Syst
Rev. 2014; 2:CD010449.
56.
Musto A, Grassetto G, Marzola MC, Chondrogiannis S, Maffione AM,
Rampin L et al. Role of 18F-FDG PET/CT in the carcinoma of the uterus:
a review of literature. Yonsei Med J. 2014; 55(6):1467-72.
57. Xiao Y, Wei J, Zhang Y, Xiong W. Positron emission tomography alone,
positron emission tomography-computed tomography and computed
tomography in diagnosing recurrent cervical carcinoma: a systematic review
and meta-analysis. Arch Med Sci. 2014; 10(2):222-31.
58.
Ding X, Feng L, Ma L. Diagnosis of recurrent uterine cervical cancer: PET
versus PET/CT: a systematic review and meta-analysis. Arch Gynecol Obstet.
2014; 290(4):741–7.